Compound 25c was previously synthesized by Brand and co-workers and studied for its ability to selectively degrade CDK6 over CDK4, in particular the correlation between the use of the CDK6 degrader in acute myeloid leukemia cells was investigated [97]. The gene discussed is CDK6; the disease is acute myeloid leukemia.